Study on HPV in Diagnoses of Atypical Glandular Cells (AGC)

What we are studying

The main purpose of this study is to determine whether the presence of human papillomavirus (HPV) and certain chemical substances (biomarkers) in cervical cells can help identify which women with a diagnosis of AGC have a benign condition and which have a pre-cancerous condition or an invasive cancer that requires surgical removal.

Who we are studying

  • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • Ages 18+

Eligibility Criteria

  • Cytologic diagnosis of AGC
  • Patients with positive or negative HPV results

What is involved

  • The amount of time each patient will be on study will vary. After you are enrolled and the result of your H-HPV testing is positive you will continue on this study until you have a complete evaluation of your cervix. This evaluation needs to be completed within 6 months from the time of your initial diagnosis of AGC.
  • If HPV results are positive or negative you can choose to have a LEEP/LETZ or cone biopsy or hysterectomy.

Compensation

None

Contact Information

Study Coordinator
Melissa Swain
Email
mswain@wakehealth.edu
Phone
336-716-9428

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.